Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
BPC-157s effects on multiple neurotransmitter systems create theoretical interaction points with psychiatric medications, yet interactions are not well studied. Particular concerns include serotonin syndrome risk when combined with SSRIs (since BPC-157 modulates serotonin in complex regional patterns), unpredictable effects on dopaminergic medications (antipsychotics, ADHD treatments, Parkinsons medications), and unknown interactions with benzodiazepines despite the animal studies showing tolerance prevention
Empirical Wolverine 250 g of each, twice a week
Patients with higher white matter hyperintensities have significantly higher BBB leakage as evaluated by DCE-MRI (227)
MacQueen and Frodl, 2011)
For more information, visit infiniwell.com
